COMMENTARY: Promoting Early Detection of Breast Cancer and Care Strategies for Nigeria

Agatha Ogunkorode, Lorraine Holtslander, June Anonson, Johanna Maree


Breast cancer is the most common cancer in women particularly in developing countries like Nigeria, with high mortality, and economic costs. Worldwide, it is predicted that more than one million women are diagnosed with breast cancer, and more than 400,000 will die from the disease every year. A comparative integrative review of the literature from Nigeria and Canada showed that in Canada, there is positive association between wide spread education, early detection, the disease stage at diagnosis, and survival rates. In Nigeria, presentation with the advanced stage of the disease makes survival very low. The primary factors responsible for the late presentations are lack of awareness, misconceptions about breast cancer causes, and treatment outcomes. It is recommended that guidelines and policies about breast cancer early detection, care strategies, and ongoing management pathways be produced, disseminated, and adopted. The guidelines will assist practitioners and patients in making informed decisions and choices about the most appropriate health care for their specific clinical situations. The implementation of evidence-based guidelines will most likely help to improve care processes, the quality of clinical decisions and patient treatment outcome. (Afr J Reprod Health 2017; 21[2]: 18-25).

Full Text:



GLOBOCAN. Cancer incidence, mortality, and

prevalence worldwide. International Agency for Research on Cancer (IARC 2012-2014).

Jemal A, Center MM, DeSantis C, and Ward ED. Global

patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology. Biomarkers Prevention 2011; 19, 1893-1907.

Yip CH and Taib A. Challenges in the management of

breast cancer in low-and middle –income countries. Future Oncology 2012; 8(12), 1575.

Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G,

Armstrong L, Awn R, Blayney D, Chen L, Feachen R, Gospodarowicz M, Gralow J, Gupta S, Langer A, Lob-Levyt J, Neal C, Mbewu A, Mired D, Piot P, Reddy KS, Sachs JD, Sarhan M and Seffrin, JR. Expansion of cancer care and control in countries of low and middle income: A call to action. The Lancet 2010; 376(9747), 1186-1193. doi:10.1016/S0140-6736(10)61152-X

Jenson OM, Parkin DM, MacLenna R, Muir CS and

Skeet RG. Cancer registration: Principles and methods. IARC Scientific Publications No. 95. Lyon, France. International Agency for Research on Cancer 1991.

Oluwatosin OA and Oladapo O. Knowledge of breast

cancer and its early detection measures among rural women in Akinyele Local Government Area of Ibadan, Nigeria. BMC Cancer 2006; 6, 271. Retrieved from http:/

Oluwatosin OA. Assessment of women's risk factors for

breast cancer and predictors of the practice of breast self-examination in two rural areas near Ibadan, Nigeria. Cancer Epidemiology 2010; 34, 425-428. doi:10.1016/j.canep.2010.04.005

Pruitt L, Mumuni T, Raikhel E, Ademola A, Ogundiran T,

Adenipekun A, Morhason-Bellow I, Ojengbede OA and Olapade OI. Social barriers to diagnosis and treatment of breast cancer in patients presenting at a teaching hospital in Ibadan, Nigeria. Global Public Health: An International Journal of Research, Policy and Practice 2015; 10(3), 331-344.

Richards L. Defining a global research agenda for breast

cancer. Cancer 1999; 113, 2366-2371.

Anderson BO, Yip CH, Smith RA, Roman S, Sener SF,

Eniu A, Carlson RW, Azavedo E and Harford J. Guideline implementation for breast healthcare in low-income and middle-income countries: Overview of breast the Breast Health Global Initiative Global Summit 2007. Cancer 2008; 113(Supplement), 2221-2243.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and

Parlin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2008; 136(5), 359-386. doi:10,1002/ijc.29210

Porter P. " Westernizing" women's risks? Breast cancer in

lower -income countries. New England Journal of Medicine 2008; 358, 213-216.

Parkin D and Fernandez L. Use of statistics to access the

global burden of breast cancer. Breast Journal, 12(Suppl.1), S81-90. Cancer 2006; 113(8), 2221-2243.

Anderson BO, Shyyan R and Eniu A. Breast cancer in

limited-resource countries: An overview of the Breast Health Global Initiative guidelines. Breast Journal 2005; 12(1), S3-S15.

Jedy-Agba E, Curado MP, Ogunbiyi O, Oga E, Fabowale

T, Igbinoba F and Adebamowo C A. Cancer incidence in Nigeria: A report from population-based cancer registries. Cancer Epidemiology 2012; 36(5), e271-e278. doi:

Ogunkorode A, Holtslander L, Anonson J and Maree J. An

integrative review of the literature on the determinants of health outcomes of women living with breast cancer in Canada and Nigeria from 1990 to 2014: A comparative study. International Journal of Africa Nursing Sciences (2017), 6, 52-73. doi:

Ajekigbe AT. Fear of mastectomy: The most common

factor responsible for the late presentation of carcinoma of the breast in Nigeria. Clinical Oncology Research 1991; 3(2), 78- 80.

Ibrahim NA and Oludara MA. Socio-demographic factors

and reasons associated with delays in breast cancer presentation: A study in Nigerian women. Breast 2012; 21(3), 416-418.

Yip CH, Smith RA, Anderson BO, Miller AB, Thomas

DB, Ang ES, Caffarella RS, Corbex M and McTiernan DB. Guideline implementation for breast healthcare in low and middle-income countries: Early detection resources allocation. Cancer 2008; 113(8), 2244-2256.

Ozmen V and Anderson BO. The challenge of breast

cancer in low-middle-income countries: Implementing the breast health global initiative guidelines global summit. BMC Cancer 2008; 6, 271. Retrieved from http:/

Anderson BO. Breast cancer—thinking globally. Science

; 343, 6178.

Sloan FA and Gelband H. Cancer control opportunities in

low-and middle-income countries 2007. Washington, DC: National Academies Press.

Shulman LN, Willet W, Sievers A and Knaul FM. Breast

cancer in developing countries. Opportunities for improved survival. Journal of Oncology 2010; doi:10.1155/2010/595167.

Ragaz J and Wong H. Comparative analysis of breast

cancer (BrCa) mortality reduction among regions of Canada between 1950-2004: Impact of systemic and diagnostic guidelines after 1977 with model definition of a number of potentially avoided annual deaths (N-PAAD). Cancer 2009; 69(24), 2063.

Yip CH, Buccimazza I, Hartman M, Deo SVS and Cheung

PSY. Improving outcomes in breast cancer for low and middle income countries. World Journal of Surgery 2011; 39, 686-692.

Breast Health Global Initiative.The Global submit on

International Breast Health: Optimizing healthcare delivery. Seattle, WA. Retrieved from GlobalPortfolio/globalsummit/pages/Program.aspx:2010.

World Health Organization. Guide for effective programs:

Cancer control: Knowledge into action: Module 3: Early Detection. Retrieved from

Yip C, Cazep E, Anderson BO, Bright KL, Caleffi M,

Cardoso F, Elzawawy AM, Masood S, Murillo R, Muse IM and Khaled HM. Breast cancer management in middle-resource countries ( MRCs): A consensus statement from the Breast Health Global Initiative. The Breast 2011; 20, S12-S19.

Mitra I. Screening for breast cancer: Is it globally

applicable? National Clinical Practice of Oncology 2008; 5(2), 60-61.

Yip CH, Smith RA, Anderson BO, Miller AB, Thomas

DB, Ang E, Caffarella RS, Corbex M and McTiernan A. Guideline implementation for breast cancer in low-income and middle-income countries: Overview of the Breast Health Global Initiative Global summit 2007. Cancer 2008; 113(8), 2221-2243.

Anderson BO. The breast health global initiative: Why it

matters to all of us. Oncology 2010; 30(24), 1230-1238.

Durosimi M. Cancer control in an economically

disadvantaged setting: Nigeria, an article in Rodrigues, B. (eds). The International Network for Cancer Treatment and Research. Summer, 2004 in African Organization for Research and Training in Cancer (AORTIC) NEWS: The Pulse of Africa 2006; 7, 25.

World Health Organization. Screening for Breast Cancer.

WHO. Retrieved from

World Health Organization. Definition of palliative care.

Retreave from

Eniu A, Carlson RW, El-Saghir NS, Bines J, Bese NS and

Vorobiof D. Guideline implementation for breast healthcare in low and middle-income countries:Treatment resource allocation. Cancer 2008;113(8), 2269-2281.

Adenipekun A, Onibokun A, Elumelu TN and Soyannwo

OA. Knowledge and attitudes of terminally ill patients and their family to palliative care and hospice services in Nigeria. Nigerian Journal of Clinical Practice 2005; 8(1), 19-22.

Bosnjak S, Maurer MA and Ryan KM. Improving the

availability and accessibility of opioids for the treatment of pain. The International Pain Policy Fellowship. Support Care Cancer 2011; 19, 1239-1247.

World Health Assembly. 58th World health Assembly

22. Resolution and detection-Cancer prevention and controls. WHA58.22. Geneva, Switzerland: World Health Organization. Retrieved from WHA58_22-en.pdf 2005

Coughlin SS and Ekwueme DU. Breast cancer as a global

health concern. Cancer Epidemiology 2009; 33, 315-318.

Adisa AO, Lawal OO and Adesunkanmi AK. Breast

cancer in Nigeria: Is non-adherence to chemotherapy schedules a major factor in the reported poor treatment outcome? The Breast Journal 2010; 16(2),206-207. doi10.1111/j.1524-4741.2009. 00883. x

Smith LK, Pope C and Botha JL. Patient‘s help-seeking

experiences and delay in cancer presentations: A qualitative synthesis. The Lancet 2005; 366, 825-831.doi:10.1016/S0140-6736(5)67030-4.


  • There are currently no refbacks.